{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:45:01Z","timestamp":1787071501319,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Comparison of available first line agents for treating Erectile Dysfunction (ED) with each other regarding efficacy in Indian context remains scant. Sexual and mental health disorders frequently overlap and it is prudent to explore the potential of these medications to improve common comorbid psychiatric symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To compare the efficacy of on-demand Sildenafil, on-demand Tadalafil and daily Tadalafil for ED, as well as their impact on premature ejaculation (PME) and mental health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Seventy-five individuals diagnosed with ED (ICD-11) were randomly assigned to one of the three treatment groups with 25 participants in each group: Group A (Sildenafil 50\u2013100 mg SOS), Group B (Tadalafil 10\u201320 mg SOS), and Group C (Tadalafil 5 mg daily). Severity of sexual functioning was evaluated using the International Index of Erectile Function (IIEF), Sexual Encounter Profile question 2 and 3 (SEP2\/3), Premature Ejaculation Diagnostic Tool (PEDT). Depression, Anxiety, and Stress Scale (DASS-21) assessed mental health status. Assessments were repeated at 2 weeks intervals till 12 weeks. Blood investigations were carried out at baseline and at the end of study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Daily<\/jats:italic>\n                      Tadalafil was superior to\n                      <jats:italic toggle=\"yes\">on-demand<\/jats:italic>\n                      Sildenafil or Tadalafil in improving erectile function (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05), particularly in penetration (SEP 2\/3) and was equally effective as\n                      <jats:italic toggle=\"yes\">on-demand<\/jats:italic>\n                      Tadalafil on IIEF, while outperforming Sildenafil. It also significantly reduced depression and anxiety symptoms at 12 weeks (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05).\n                      <jats:italic toggle=\"yes\">On-demand<\/jats:italic>\n                      Tadalafil was most effective for managing associated PME, which was comorbid with ED in 66.7% of cases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Daily Tadalafil<\/jats:italic>\n                      was more effective than\n                      <jats:italic toggle=\"yes\">on-demand<\/jats:italic>\n                      Tadalafil or Sildenafil for treating ED, especially in patients with mood symptoms. PME was found to be quite common with ED and responded best to on demand Tadalafil. Tadalafil was superior to Sildenafil in all domains.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/indianjpsychiatry_998_24","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:00:14Z","timestamp":1766070014000},"page":"1136-1144","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy of on-demand Sildenafil, Tadalafil and daily Tadalafil for treatment of erectile dysfunction: A 12-week randomized controlled study"],"prefix":"10.4103","volume":"67","author":[{"given":"Shevya","family":"Gagal","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Government Medical College and Hospital, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajeet K.","family":"Sidana","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Government Medical College and Hospital, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Government Medical College and Hospital, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarndeep","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, VMMC and Safdarjung Hospital, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.ijir.3900949","article-title":"Epidemiology of erectile dysfunction","volume":"15","author":"Kubin","year":"2003","journal-title":"Int J Impot Res"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000477496","article-title":"Efficacy and safety of tadalafil once-a-day versus tadalafil on-demand in patients with erectile dysfunction: A systematic review and meta-analyses","volume":"99","author":"Peng","year":"2017","journal-title":"Urol Int"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/0019-5545.158143","article-title":"An epidemiological study of sexual disorders in south Indian rural population","volume":"57","author":"Sathyanarayana Rao","year":"2015","journal-title":"Indian J Psychiatry"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1097\/01.ju.0000125198.32936.38","article-title":"The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction","volume":"171","author":"Seftel","year":"2004","journal-title":"J Urol"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"e20546","DOI":"10.1097\/MD.0000000000020546","article-title":"Effect of daily tadalafil on reported outcomes in patients with erectile dysfunction and depressive symptoms: STROBE, a case\u2013control study","volume":"99","author":"Kim","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ijir.3900857","article-title":"The International Index of Erectile Function (IIEF): A state-of-the-science review","volume":"14","author":"Rosen","year":"2002","journal-title":"Int J Impot Res"},{"issue":"Suppl 1","key":"R7-20260420","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.4103\/0019-5545.196977","article-title":"Clinical practice guidelines for management of sexual dysfunction","volume":"59","author":"Avasthi","year":"2017","journal-title":"Indian J Psychiatry"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41443-018-0019-5","article-title":"Low dose daily versus on-demand high dose tadalafil in diabetic patients with erectile and ejaculatory dysfunction","volume":"30","author":"Bolat","year":"2018","journal-title":"Int J Impot Res"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1743-6109.2005.20360.x","article-title":"Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction","volume":"2","author":"McMahon","year":"2005","journal-title":"J Sex Med"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.18410\/jebmh\/2020\/554","article-title":"A prospective randomized comparative study to evaluate the effect of once daily dose of tadalafil (5 mg) vs on-demand tadalafil (10 mg) on international index for erectile function (IIEF) score","volume":"7","author":"Ali","year":"2020","journal-title":"J Evid Based Med Healthc"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1743-6109.04042.x","article-title":"Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil","volume":"1","author":"McMahon","year":"2004","journal-title":"J Sex Med"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0090-4295(03)00359-5","article-title":"Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: A randomized controlled trial","volume":"62","author":"Porst","year":"2003","journal-title":"Urology"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"852","DOI":"10.4111\/kju.2006.47.8.852","article-title":"A randomised, double-blind, parallel, placebo-controlled study of the efficacy and safety of tadalafil administered on-demand to men with erectile dysfunction in Korea","volume":"47","author":"Choi","year":"2006","journal-title":"Korean J Urol"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4172\/1488-5069.1000064","article-title":"Vardenafil: A new and effective treatment for erectile dysfunction","volume":"3","author":"Casey","year":"2003","journal-title":"J Sex Reprod Med"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.eururo.2007.01.028","article-title":"Development and validation of a premature ejaculation diagnostic tool","volume":"52","author":"Symonds","year":"2007","journal-title":"Eur Urol"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/psychiatry.IndianJPsychiatry_716_20","article-title":"A systematic review of Indian studies on sexual dysfunction in patients with substance use disorders","volume":"63","author":"Sarkar","year":"2021","journal-title":"Indian J Psychiatry"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1464-410X.2005.05892.x","article-title":"An open\u2010label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men na\u00efve to phosphodiesterase 5 inhibitor therapy","volume":"96","author":"Eardley","year":"2005","journal-title":"BJU Int"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.ijir.3901525","article-title":"Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?","volume":"19","author":"Doggrell","year":"2007","journal-title":"Int J Impot Res"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1517\/14656566.6.1.75","article-title":"Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction","volume":"6","author":"Doggrell","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jsxm.2016.02.171","article-title":"Efficacy of continuous dosing of tadalafil once daily vs tadalafil on demand in clinical subgroups of men with erectile dysfunction: A descriptive comparison using the integrated tadalafil databases","volume":"13","author":"Brock","year":"2016","journal-title":"J Sex Med"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/aja.2009.11","article-title":"Efficacy and safety of tadalafil taken as needed for the treatment of erectile dysfunction in Asian men: Results of an integrated analysis","volume":"11","author":"Guo","year":"2009","journal-title":"Asian J Androl"},{"key":"R27-20260420","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.esxm.2019.06.006","article-title":"Meta-analysis of the long-term efficacy and tolerance of tadalafil daily compared with tadalafil on-demand in treating men with erectile dysfunction","volume":"7","author":"Zhou","year":"2019","journal-title":"Sex Med"},{"key":"R28-20260420","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1743-6109.2011.02507.x","article-title":"Premature ejaculation and erectile dysfunction prevalence and attitudes in the Asia-Pacific region","volume":"9","author":"McMahon","year":"2012","journal-title":"J Sex Med"},{"key":"R29-20260420","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2605.2005.00593.x","article-title":"Correlation between ejaculatory and erectile dysfunction","volume":"28","author":"Jannini","year":"2005","journal-title":"Int J Androl"},{"key":"R30-20260420","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41443-018-0099-2","article-title":"Sildenafil\/Viagra in the treatment of premature ejaculation","volume":"31","author":"Krishnappa","year":"2019","journal-title":"Int J Impot Res"},{"key":"R31-20260420","doi-asserted-by":"crossref","first-page":"e13005","DOI":"10.1111\/and.13005","article-title":"Efficacy and safety of daily use of tadalafil in treatment of patients with premature ejaculation: A randomised placebo\u2010controlled clinical trial","volume":"50","author":"Abu El\u2010Hamd","year":"2018","journal-title":"Andrologia"},{"key":"R32-20260420","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1442-2042.2007.01606.x","article-title":"Can sildenafil treat primary premature ejaculation? A prospective clinical study","volume":"14","author":"Wang","year":"2007","journal-title":"Int J Urol"},{"key":"R33-20260420","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jsxm.2018.05.016","article-title":"Erectile dysfunction and depression: A systematic review and meta-analysis","volume":"15","author":"Liu","year":"2018","journal-title":"J Sex Med"}],"container-title":["Indian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/indianjpsychiatry_998_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:47:02Z","timestamp":1787068022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/indianjpsychiatry_998_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/indianjpsychiatry_998_24","relation":{},"ISSN":["0019-5545","1998-3794"],"issn-type":[{"value":"0019-5545","type":"print"},{"value":"1998-3794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"2024-11-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}